GRIFOLS
Grifols is a global healthcare company. Grifols operates in three segments: Bioscience, Hospital, and Diagnostic. The Bioscience segment engages in the research, development, production, and commercialization of plasma derivates. The Diagnostic segment focuses on researching, developing, manufacturing, and marketing diagnostics products for laboratory analysis, including products for hospital blood banks and transfusion centers.
GRIFOLS
Industry:
Biotechnology Health Care Manufacturing
Founded:
1940-01-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.grifols.com
Total Employee:
10001+
Status:
Active
Contact:
(349) 357-1220
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Font Awesome Domain Not Resolving
Similar Organizations
BioGaia
BioGaia is an innovative Swedish health care company.
Biotech
Biotech is a healthcare company.
Btm Products
Btm Products is a healthcare company.
Calimmune
Calimmune is a clinical-stage gene therapy company.
ESTEVE
ESTEVE is a healthcare company in Spain.
Gematik
Gematik is an electronic health card development company.
Geneius
Geneius is a Biotechnology company.
GeneReach Biotechnology
GeneReach Biotechnology is a global health care company.
Glaxo Group
Glaxo Group is a science-led global healthcare company.
HLL Lifecare LTD
Our vision is to become a INR 10,000 crore global healthcare company by 2020.
HRW
HRW is a global healthcare research agency.
Insights Learning and Development Ltd
The Insights Group Ltd. is a global people development company.
Interpace Biosciences
Interpace Biosciences is a leading health care commercialization company.
KSEP
KSEP is a Health Care company.
MSD
MSD is an research-based healthcare company.
Novolog
Novolog is an Israeli health logistics company.
Samsung BioLogics
Samsung BioLogics is a health care company.
Xerion
Xerion is a consumer healthcare company.
Current Advisors List
Board_member
2006-04-01
Board_member
2015-01-01
Board_member
Board_member
2000-04-01
Board_member
Board_member
1997-01-01
Board_member
Board_member
Current Employees Featured
Carina Szpilka Independent Director @ Grifols
Independent Director
2015-05-01
Grífols Roura President & Chief Executive Officer @ Grifols
President & Chief Executive Officer
Chris McCall Sr. Director, Head of Global Supply Chain @ Grifols
Sr. Director, Head of Global Supply Chain
2014-11-01
Víctor Deu Director of Planning & Control Department @ Grifols
Director of Planning & Control Department
2008-01-01
Ramon Riera Vice President of Marketing & Sales @ Grifols
Vice President of Marketing & Sales
1988-01-01
Suzanne Johnson Director of Human Resources @ Grifols
Director of Human Resources
2011-06-01
Josep Antoni Grífols i Roig Founder @ Grifols
Founder
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-04-25 | Biotest | Biotest acquired by Grifols | 2 B EUR |
| 2021-03-09 | GigaGen | GigaGen acquired by Grifols | 80 M USD |
| 2020-09-07 | Alkahest | Alkahest acquired by Grifols | 146 M USD |
| 2018-01-26 | MedKeeper | MedKeeper acquired by Grifols | 98 M USD |
| 2017-01-31 | Hologic - NAT donor screening unit | Hologic - NAT donor screening unit acquired by Grifols | 1.85 B USD |
| 2014-09-19 | Kiro Robotics | Kiro Robotics acquired by Grifols | 21 M EUR |
| 2013-05-03 | Progenika Biopharma | Progenika Biopharma acquired by Grifols | 37 M USD |
| 2012-03-19 | Araclon Biotech | Araclon Biotech acquired by Grifols | N/A |
| 2010-06-07 | Talecris Biotherapeutics | Talecris Biotherapeutics acquired by Grifols | 3.4 B USD |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2017-07-07 | GigaGen | Grifols investment in Funding Round - GigaGen | 35 M USD |
| 2016-06-01 | Singulex | Grifols investment in Funding Round - Singulex | 50 M USD |
| 2015-03-04 | Alkahest | Grifols investment in Corporate Round - Alkahest | 37.5 M USD |
| 2013-05-08 | Celyad | Grifols investment in Venture Round - Celyad | 19 M EUR |
| 2012-07-09 | VCN Biosciences | Grifols investment in Funding Round - VCN Biosciences | N/A |
| 2009-01-19 | Celyad | Grifols investment in Series B - Celyad | 7.2 M EUR |
Official Site Inspections
http://www.grifols.com Semrush global rank: 149.56 K Semrush visits lastest month: 575.19 K
- Host name: 193.142.217.179
- IP address: 193.142.217.179
- Location: Spain
- Latitude: 40.4172
- Longitude: -3.684
- Timezone: Europe/Madrid
More informations about "Grifols"
Leadership - grifols.com
The information contained on the Grifols worldwide website is not applicable to all countries. For specific information on the products and services available in your country, please select your …See details»
Biopharma & Healthcare Solutions | Grifols
Feb 26, 2025 Grifols expects to reach EUR 10 billion in revenue, EUR 2.9 billion in EBITDA and EUR 3.5+ billion in cumulative cash flow by 2029. February 27, 2025 Read Release Read Release Show more news. Commitment to people …See details»
Company | Grifols
Grifols is a global healthcare company that since 1909 has enhanced the health and well-being of people around the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide …See details»
About Grifols - Diagnostic
In addition, Grifols supplies tools, information, and services that enable hospitals, pharmacies, and healthcare professionals to efficiently deliver expert medical care. Grifols, with more than …See details»
About Grifols - HDA portal
In addition, Grifols supplies tools, information, and services that enable hospitals, pharmacies, and healthcare professionals to efficiently deliver expert medical care. Grifols, with more than …See details»
Grifols in your community
Grifols is a long-time partner of Habitat for Humanity both locally and nationally. Over the years, Grifols employees have participated on multiple Habitat house and playground builds. Habitat …See details»
Org Chart Grifols - The Official Board
The organizational chart of Grifols displays its 72 main executives including Nacho Abia, Rahul Srinivasan and David Bell. Toggle navigation The Official Board. Search. Search. Search by segment. Sign In. Business E-mail* …See details»
Mission, vision and values - Grifols.com
The information contained on the Grifols worldwide website is not applicable to all countries. For specific information on the products and services available in your country, please select …See details»
Home - Grifols Plasma Canada
Welcome to Grifols, formerly known as Prometic Plasma Resources. We are transitioning to a new website and brand. You will see this new brand online and at our centre as we make …See details»
A New Era of Blood Safety - diagnostic.grifols.com
Oct 22, 2024 Grifols has been addressing these challenges since the mid-2000s. However, testing for multiple viruses strains resources and budgets. Introducing the Procleix ArboPlex …See details»
Jobs | Grifols
Grifols is committed to Equal Employment Opportunity (EEO) and to compliance with all Federal, State and local laws that prohibit employment discrimination on the basis of race, color, age, …See details»
About Grifols Egypt - Grifols Egypt for Plasma Derivatives
About Grifols Egypt for Plasma Derivatives (GEPD) Grifols Egypt for plasma derivatives is a joint-venture (JV) company between the Egyptian Government, through the National Service …See details»
Grifols - Contacts, Employees, Board Members, Advisors & Alumni
Grifols has 13 board members and advisors, including Thomas Glanzmann. Thomas Glanzmann Board Member Apr 2006. Nuria Martin Board Member 2015. Marla Salmon Board Member. …See details»
Kiro Grifols – Kiro Grifols
Kiro Grifols; Contact Us; Robotic and Other Compounding Devices. Solutions Designed to Keep Your Patients Safe. Your most important responsibility is patient safety, but you are also …See details»
Full-Year 2024 Financial Results - grifols.com
The information contained on the Grifols worldwide website is not applicable to all countries. For specific information on the products and services available in your country, please select your …See details»
Grifols delivers a strong 2024 exceeding guidance on revenue and …
Feb 26, 2025 Rahul Srinivasan, Chief Financial Officer, said, “Grifols delivered a strong finish to cap off our second consecutive record year, a testament to the commitment and drive of our …See details»
Techdocs Home - Salesforce
Grifols Customer Portal. Your on-demand digital hub that transforms the way you work! Our platform goes beyond simplifying daily routines with ease and efficiency. It empowers you do …See details»
Home Page Official - Grifols.com
Grifols, weltweit führend im Gesundheitswesen bei der Herstellung von aus Plasma gewonnenen Arzneimitteln und anderen innovativen biopharmazeutischen Lösungen, setzt sich für die …See details»
Healthcare Innovation For Patients | Grifols
Grifols treatments center on immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases. Each area features therapies helping patients …See details»
Grifols to acquire Green Cross plasma fractionation facility in ...
Barcelona, Spain, July 20, 2020. - Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global healthcare company and one of world’s top producers of plasma-derived medicines, today …See details»